Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
about
Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancerTargeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enoughImmunohistochemical detections of EGFR mutations in NSCLCA graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryAscertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysisIdentification of EGFR Mutations by Immunohistochemistry with EGFR Mutation-Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma.Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicinFluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.Prognostic and predictive biomarkers in lung cancer. A review.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study.Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells.Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry.Molecular insights: Suppression of EGFR and AKT activation by a small molecule in non-small cell lung cancer.Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis.Molecular diagnostic algorithm for epidermal growth factor receptor mutation detection in Asian lung adenocarcinomas: comprehensive analyses of 445 Taiwanese patients with immunohistochemistry, PCR-direct sequencing and Scorpion/ARMS methods.EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.Molecular alterations of EGFR in small intestinal adenocarcinoma.Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma.[Immunohistochemical detections of EGFR status in NSCLC].Diamond: immunohistochemistry versus sequencing in EGFR analysis of lung adenocarcinomas.Detecting EGFR alterations in clinical specimens-pitfalls and necessities.[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.[Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations].
P2860
Q26781810-DFEDA9E6-7C67-434B-B138-B82ED34D027CQ26799467-08383F1B-0E81-402B-ACAF-30E8892A4802Q26866152-5588E8C8-5E1E-49EE-B24B-5E17FA867EE4Q30360645-07CF7AF9-24D2-4EE2-8779-7C50DDC7AE07Q34359601-9F77ED86-2390-4F48-A0AA-6F7A232698D2Q34405695-73FD7A65-6787-455A-8BDF-66C4719D89C2Q34639632-5CB1F985-D454-4CEA-AC10-5DDD84BA40F7Q35244225-0623E93A-06A2-44D2-8A27-2E620B0F2440Q36186935-E1E930DF-02FD-452F-BFB5-F88F68C64FD0Q36207113-68829E7F-7038-4719-AAC5-645832C13312Q36512623-49963120-EFCE-48CB-9E59-D9444B903BB8Q37345952-C493DF17-96C7-459B-995E-89D8F96450A4Q38061599-C8E0CCBE-7052-4CDA-BB0C-7052FD985A37Q38178187-958FB072-2A5F-4C20-9DBD-5FD453D65AABQ38719813-9D2F164F-408C-44C7-9F6C-D495F973DE3BQ38994695-3BCF14D2-722F-4752-ABD6-1F28D63FAC3DQ39110498-9909C771-D51D-4AA4-88A4-CEBE114C29F6Q40097709-E83FDE37-F8E0-4EB5-813F-60F773FA43BBQ47093966-7CD4E45D-36EC-4E01-930F-DA94F9B9F61EQ47130055-4A08B63D-30D0-40D1-8D5D-B71FE6CD608FQ47766194-32FC3B81-B2FC-408A-A279-D170E5D46A4EQ48458378-4D3AF397-E265-4341-9DD2-A665DF460D8CQ50916986-8C65AAB5-DC85-47AB-8C4C-C5BD9BCB8496Q51019080-DD316020-38F3-436E-B478-A0EB06A230C2Q51046274-0E15C2B2-5094-4228-941D-DF9AB977F5FFQ51493734-4CBF8E6C-F9B6-444C-A74C-C73B3FDEA11FQ52903547-81FF0670-19FA-456F-8658-5214CA74B2B1Q53085284-2DAF12CC-152A-4DB2-ADC7-D85440213E54Q54343325-1AB25DC2-3130-47A0-AE9E-0DBA2E9B1F4FQ54395887-ED34E40E-D279-4FEC-9FA8-A95702E91547Q55033406-B1D9920E-BFB1-4F98-A85D-A4AD80995687
P2860
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@ast
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@en
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@nl
type
label
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@ast
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@en
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@nl
prefLabel
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@ast
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@en
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@nl
P2093
P2860
P50
P356
P1476
Detection of EGFR mutations wi ...... IV non-small-cell lung cancer.
@en
P2093
Bartomeu Massuti
Clara Mayo
Cristina Queralt
Dolores Isla
Itziar de Aguirre
Jordi Bertran-Alamillo
Jose Luis Gonzalez-Larriba
José Javier Sanchez
Miguel Angel Molina
Miquel Taron
P2860
P2888
P356
10.1186/1479-5876-8-135
P577
2010-12-18T00:00:00Z
P5875
P6179
1023416483